Full-Time
Representative
Internal Service
Sysmex
1,001-5,000 employees
Manufactures automated hematology analyzers and diagnostics
Compensation Overview
$18.87 - $27.50/hr
Mundelein, IL, USA
In Person
Up to 25% travel required.
 IT & Security (1) |
|---|
Get referred to Sysmex
See people who can refer or advise you
- A High School diploma/GED or three years of required experience in telephone and customer service skills, which may include experience in the Armed Forces.
- A valid driver’s license is required.
- Experience in remote customer service, electronics, laboratory or biomedical technology, military experience in a technical field, or equivalent is required.
- Proficiency with MS skills, networking, and CFM software is required.
- The ability to explain and interpret complex information with patience and understanding is required.
- Telephone and customer service skills are required.
- Provide direct technical assistance to customers over a toll-free telephone hotline.
- Remotely upgrade software, troubleshoot issues to resolution, and document customer calls within the customer relationship management system.
- Maintain and conform to procedures and documentation meeting regulatory and International Organization for Standardization guidelines, including validating all analyzers before releasing them to customers to ensure they meet quality specifications.
- Maintain inventory and shipping processes for instrumentation and necessary parts supporting the Service Center.
- Adhere to strict decontamination guidelines when receiving customer-returned units.
- Manage inventory of parts, tools, consumables, and reagents at the Service Center.
- Follow proper guidelines for handling and storing biohazard materials.
- Support dock management with shipping and receiving packages for Mundelein Building 1.
- Perform other assigned duties.
Sysmex designs and sells instruments and reagents for in-vitro diagnostics, with a focus on automated hematology analyzers that count and evaluate blood cells, enabling clinical decision-making. Over time, it expanded into genetics through the acquisition of Oxford Gene Technology and into rapid antimicrobial testing with Astrego, broadening its diagnostic portfolio. The company differentiates itself by growing through acquisitions to build a diverse, global product line and by maintaining a strong brand presence in workflows for hematology, genetics, and infectious disease testing across more than 190 countries. Its goal is to provide essential, reliable diagnostic tools that support healthcare worldwide, helping clinicians diagnose and treat diseases faster and more accurately.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Kobe, Japan
Founded
1968
Get referred to Sysmex
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q1 FY2027 sales rose 23.6% and operating profit jumped 39.5% year over year.
- Americas, EMEA, and AP strength offset China weakness, proving geographic diversification works.
- Fiscal 2027 guidance raised to ¥545 billion sales and ¥60 billion operating profit.
What critics are saying
- China healthcare cost containment crushed hemostasis volumes, especially D-Dimer, in 2026.
- FY2026 operating profit fell 40.8% to ¥51.8 billion, exposing margin fragility.
- Mindray keeps taking Chinese hematology share; continued losses there erode Sysmex's core moat.
What makes Sysmex unique
- XN and XR hematology platforms keep Sysmex entrenched in high-complexity labs.
- CN-9000 and XR-Series extend modular automation across coagulation and hematology workflows.
- Sysmex BioMajesty broadens diagnostics into clinical chemistry after the JEOL acquisition.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Paid Time Off
Parental Leave
Bereavement Leave
401(k) Retirement Plan
401(k) Company Match
Annual Incentive Bonus
Growth & Insights and Company News
6 month growth
↑ 32%1 year growth
↑ 32%2 year growth
↑ 32%Sysmex America unveils next generation XR-Series to streamline hematology testing. Sysmex America introduces the XR-Series, featuring the XR-10 Automated Hematology Module, designed to deliver fast, reliable results with improved analytics and workflow efficiency for busy laboratories. May 29, 2026 Sysmex America, Inc. has unveiled the next generation XR-Series, a hematology solution designed to help busy laboratories deliver fast, reliable results while maintaining efficient workflows. At the center of the new system is the XR-10 Automated Hematology Module, built for high-complexity laboratories that need speed, consistency and dependable performance. The next-generation XR-Series builds on the trusted capabilities of the popular XN-Series, adding higher throughput, enhanced analytics and complementary solutions that streamline daily lab operations. Enhancements to the WBC differential reagent, combined with innovative 3D scattergram visualization and the optional WPC channel on the XR-20 Automated Hematology Module, provide valuable insights that support result interpretation, improve flagging accuracy and increase confidence in results. The new reagent formulation allows greater separation of cell clusters in the WDF scattergram without sacrificing accurate WBC differential flagging. For existing Sysmex hematology users, the transition is designed to be seamless. The system maintains the familiar operation and user interface of the widely adopted XN-Series while preserving its modular design. The XR-9000 configuration for high-volume labs also integrates with complementary products that help automate routine steps and increase efficiency, supporting smoother workflows across the laboratory. The new frontier of point-of-care testing. Discover how next-generation handheld diagnostics are changing medicine at the speed of care. Get the Free eBook
Sysmex America has launched the next generation XR-Series hematology solution for clinical laboratories. The system centres on the XR-10 Automated Hematology Module, designed for high-complexity labs requiring speed and consistency. Building on the XN-Series, the new platform offers higher throughput, enhanced analytics and streamlined workflows. The XR-20 module features an optional WPC channel and improved WBC differential reagent with 3D scattergram visualisation for better result interpretation and flagging accuracy. The system maintains the familiar XN-Series interface and modular design, enabling smooth transitions for existing users. The high-volume XR-9000 configuration integrates with complementary automation products. Sysmex America, based in Chicago, is the Americas regional affiliate of Kobe-based Sysmex Corporation, offering diagnostic solutions across hematology, hemostasis, urinalysis, flow cytometry and informatics.
Sysmex America introduces next generation xr-series(tm) hematology solution for clinical laboratories. Chicago - May 28, 2026 - Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and informatic solutions, has introduced the next generation XR-Series, a hematology solution designed to help busy laboratories deliver fast, reliable results while maintaining efficient workflows. At the center of the new system is the XR-10 Automated Hematology Module, built for high-complexity laboratories that need speed, consistency and dependable performance. The next-generation XR-Series builds on the trusted capabilities of the popular XN-Series(TM), adding higher throughput, enhanced analytics and complementary solutions that streamline daily lab operations. "The XR-Series reflects our commitment to helping laboratories work smarter without disrupting the workflows they depend on," said Dan Zortman, CEO of Sysmex America. "By combining proven reliability, advanced analytics and the support of our award-winning service teams, the XR-Series analyzers help laboratories deliver the accuracy and precision clinicians rely on for outstanding patient care." Enhancements to the WBC differential reagent, combined with innovative 3D scattergram visualization and the optional WPC channel on the XR-20 Automated Hematology Module, provide valuable insights that support result interpretation, improve flagging accuracy and increase confidence in results. The new reagent formulation allows greater separation of cell clusters in the WDF scattergram without sacrificing accurate WBC differential flagging. For existing Sysmex hematology users, the transition is designed to be seamless. The system maintains the familiar operation and user interface of the widely adopted XN-Series while preserving its modular design. This allows laboratories to quickly adopt the new system while benefiting from improved performance. The XR-9000(TM) configuration for high-volume labs also integrates with complementary products that help automate routine steps and increase efficiency, supporting smoother workflows across the laboratory. The next generation XR-Series is backed by Sysmex America's award-winning service and support teams, helping laboratories keep systems running smoothly and maintain confidence in their results. To learn more about the XR-Series and Sysmex America's full portfolio of hematology products, visit www.sysmex.com. About Sysmex America The combination of Sysmex America's new testing methods and innovative hematology, hemostasis, urinalysis, flow cytometry and informatic systems are transforming the future of healthcare and contributing to healthier lives. As Americas regional affiliate of Kobe, Japan-based Sysmex Corporation - a trusted global leader respected for optimizing the efficiency, operations and financial performance of clinical laboratories - it offers diagnostic products that equip patients and the healthcare professionals who treat them with the information needed to make decisions with greater trust and confidence. Forbes magazine named Sysmex one of the most innovative companies in the healthcare equipment and services category, and the Center for Companies That Care named Sysmex America to its "Honor Roll." Learn more about Sysmex America at www.sysmex.com/Sysmex America, Inc. Media Contact Julie Baron [email protected] 847-525-3043
This section provides Sysmex’s most recent news releases related to IR information, products and support, research and development, corporate information and other notifications.
Launch of "CN(TM)-9000 Automated Hemostasis Solution" for large-scale laboratories in North America - supporting the optimization of laboratory workflow - (Sysmex America). Sysmex America, Inc., a Sysmex Group company, has launched the "CN(TM)-9000 Automated Hemostasis Solution" as a new addition to the CN-Series for hemostasis testing in the North American market. This product supports further automation and increased efficiency in testing operations at large hospitals and testing centers with high test volumes. In addition to standalone operation, the CN(TM)-9000 is compatible with Total Laboratory Automation (TLA) lines, enabling flexible system configurations tailored to the size and operational needs of each laboratory. For further details, please refer to Sysmex America's press release. Going forward, Sysmex will continue to work to further enhance the value of hemostasis through product development and services that address the increasingly varied and sophisticated needs of medical settings, thereby contributing to improved patient outcomes. * The purpose of this news is to communicate its business activities to its stakeholders. It may or may not include information about Sysmex's products or their research and development, but this is not intended for promotion, advertising, or medical advice. The information contained in this press release is current as of the date of the announcement but may be subject to change without prior notice.